Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284072
Max Phase: Preclinical
Molecular Formula: C30H27NO2
Molecular Weight: 433.55
Associated Items:
ID: ALA5284072
Max Phase: Preclinical
Molecular Formula: C30H27NO2
Molecular Weight: 433.55
Associated Items:
Canonical SMILES: O=C(O)/C=C/c1c(-c2ccc(CCc3ccccc3)cc2)c(-c2ccccc2)c2n1CCC2
Standard InChI: InChI=1S/C30H27NO2/c32-28(33)20-19-27-30(29(24-10-5-2-6-11-24)26-12-7-21-31(26)27)25-17-15-23(16-18-25)14-13-22-8-3-1-4-9-22/h1-6,8-11,15-20H,7,12-14,21H2,(H,32,33)/b20-19+
Standard InChI Key: NERFLINBYIHYSS-FMQUCBEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 433.55 | Molecular Weight (Monoisotopic): 433.2042 | AlogP: 6.65 | #Rotatable Bonds: 7 |
Polar Surface Area: 42.23 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.54 | CX Basic pKa: | CX LogP: 7.44 | CX LogD: 4.66 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.33 | Np Likeness Score: -0.17 |
1. Gouda AM, Abdelazeem AH.. (2016) An integrated overview on pyrrolizines as potential anti-inflammatory, analgesic and antipyretic agents., 114 [PMID:26994693] [10.1016/j.ejmech.2016.01.055] |
Source(1):